Amphastar Pharmaceuticals, Inc.
AMPH
Revenue
186.52M
▼-4.69M▼-2.45%
3 Months ChangeAssets
1.58B
▲32.29M▲2.09%
3 Months ChangeLiabilities
845.17M
▲27.67M▲3.38%
3 Months ChangeFree Cash Flow
46.50M
▲15.59M▲50.45%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-08-30
Form 8-K
ID: 0001297184-24-000051
2024-08-09
Form 10-Q
ID: 0001297184-24-000048
2024-08-07
Form 8-K
ID: 0001297184-24-000045
2024-06-04
Form 8-K
ID: 0001297184-24-000042
2024-05-10
Form 10-Q
ID: 0001297184-24-000037
2024-05-08
Form 8-K
ID: 0001297184-24-000033
2024-02-28
Form 8-K
ID: 0001297184-24-000004
2023-11-08
Form 10-Q
ID: 0001297184-23-000082
2023-11-08
Form 8-K
ID: 0001297184-23-000079
2023-09-15
Form 8-K
ID: 0001297184-23-000074